ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction

Urology

Volumn 62, Issue 1, 2003, Pages 152-157

  Eisenhardt, Andreas ^a   Sperling, Herbert ^b   Hauck, Ekkehard ^b   Porst, Hartmut ^b   Stief, Christian ^b   Rübben, Herbert ^b   Müller, Norbert ^b   Siffert, Winfried ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; ERECTILE DYSFUNCTION; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0038679711     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00137-7     Document Type: Article

References (30)

1. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychological correlates results of the Massachusetts Male Aging Study . J Urol. 151:1994;54-61.
2. Andersson K.E. Pharmacology of penile erection. Pharmacol Rev. 53:2001;417-450.
3. Rajfer J., Aronson W.J., Bush P.A., et al. Nitric oxide as a mediator of relaxation of the corpora cavernosa in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 326:1992;90-94.
4. Andersson K.E., Wagner G. Physiology of penile erection. Physiol Rev. 75:1995;191-236.
5. Becker A.J., Ückert S., Stief C., et al. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology. 57:2001;193-198.
6. Goldstein I., Lue T., Padma-Nathan H., et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 338:1998;1397-1404.
7. Ballard S.A., Gingell C.J., Tang K., et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozyme. J Urol. 159:1998;2164-2171.
8. Padma-Nathan H., Steers W.D., Wicker P.A. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction a double-blind, placebo-controlled study of 329 patients. Int J Clin Pract. 52:1998;375-379.
9. Viagra labeling information, NDA submission. New York, Pfizer, 1997.
10. Rigat B., Hubert C., Alhenc-Gelas F., et al. An insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene accounting for half the variance of serum levels. J Clin Invest. 86:1990;1343-1346.
11. Park J.K., Kim S.Z., Kim S.H., et al. Renin angiotensin system in rabbit corpus cavernosum functional characterization of angiotensin II receptors . J Urol. 158:1997;653-658.
12. Nakayama M., Yasue H., Yoshimura M., et al. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 99:1999;2864-2870.
13. Miyamoto Y., Saito Y., Kajiyama N., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 32:1998;3-8.
14. Hibi K., Ishigami T., Tamura K., et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension. 32:1998;521-526.
15. Lindpaintner K., Pfeffer M., Kreutz R., et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 332:1995;706-711.
16. Shanmugam V., Sell K.W., Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3:1993;120-121.
17. Naber C.K., Baumgart D., Altmann C., et al. eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol. 281:2001;H1908-H1912.
18. Hsueh W.A., Tuck M.L. Aldosterone and the renin-angiotensin system. Becker K.L. Principles and Practice of Endocrinology and Metabolism. 1990;319-362 JB Lippincott, Philadelphia.
19. Kifor I., Williams G., Vickers M., et al. Tissue angiotensin II as a modulator of erectile function angiotensin peptide content, secretion and effects in the corpus cavernosum . J Urol. 157:1997;1920-1925.
20. Becker A.J., Ückert S., Stief C., et al. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology. 58:2001;805-810.
21. Iwamoto Y., Song K., Takai S., et al. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum. J Pharmacol Exp Ther. 298:2001;43-48.
22. Morgentaler A. Male impotence. Lancet. 354:1999;1713-1718.
23. Cambien F., Poirier O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
24. Marian A.J., Yu Q.T., Workman R., et al. ACE polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 342:1993;1085-1086.
25. Park J.K., Kim W., Kim S.W., et al. Gene polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with erectile dysfunction. Int J Impot Res. 11:1999;273-276.
26. Kim D.S., Choi S.I., Lee H.S., et al. Determination of human angiotensin converting enzyme (ACE) gene polymorphisms in erectile dysfunction frequency differences of ACE gene polymorphisms according to the method of analysis . Clin Chem Lab Med. 39:2001;11-14.
27. Tiret L., Rigat B., Visvikis S. Evidence from combined segregation and linkage analysis that a variant of ACE gene controls plasma ACE levels. Am J Hum Genet. 51:1992;197-205.
28. Schmidt H.H., Walter U. NO at work. Cell. 78:1994;919-925.
29. Wang X.L., Sim A.S., Wang M.X., et al. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 471:2000;45-50.
30. Philip I., Plantefeve G., Vuillaumier-Barrot S., et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation. 99:1999;3096-3098.